Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Cardinal Health | CAH | 2. avr 2025 | 138.67 | +1.12 |
Cardio Diagnostics | CDIO | 2. avr 2025 | 0.34 | -4.19 |
Cardiol Therapeutics | CRDL | 2. avr 2025 | 0.92 | -0.64 |
Cardlytics | CDLX | 2. avr 2025 | 1.82 | -3.70 |
CareCloud | CCLD | 2. avr 2025 | 1.42 | +2.90 |
CareCloud A Pref | CCLDP | 2. avr 2025 | 19.43 | 0.00 |
CareCloud B Pref | CCLDO | 2. avr 2025 | 18.83 | -0.89 |
CareDx | CDNA | 2. avr 2025 | 18.39 | +3.90 |
CareTrust REIT | CTRE | 2. avr 2025 | 28.55 | +0.25 |
CARGO Therapeutics | CRGX | 2. avr 2025 | 4.23 | +2.67 |
CarGurus A | CARG | 2. avr 2025 | 29.51 | +0.92 |
Caribou Biosciences | CRBU | 2. avr 2025 | 0.86 | +2.37 |
Carisma Therapeutics | CARM | 2. avr 2025 | 0.22 | -3.60 |
Carlisle Companies | CSL | 2. avr 2025 | 348.23 | +1.47 |
Carlyle Credit Income Fund | CCIA | 2. avr 2025 | 25.80 | 0.00 |
Carlyle Credit Income Fund | CCIF | 2. avr 2025 | 6.93 | -0.43 |
Carlyle Secured Lending | CGBD | 2. avr 2025 | 16.25 | +0.06 |
CarMax | KMX | 2. avr 2025 | 82.77 | +4.93 |
Carnival | CCL | 2. avr 2025 | 20.02 | +3.25 |
Carnival ADR | CUK | 2. avr 2025 | 18.01 | +3.15 |
CarParts.com | PRTS | 2. avr 2025 | 1.04 | +4.67 |
Carpenter Technology | CRS | 2. avr 2025 | 187.35 | +2.55 |
Carriage Services | CSV | 2. avr 2025 | 39.61 | +2.40 |
Carrier Global | CARR | 2. avr 2025 | 65.04 | +2.36 |
Cars.com | CARS | 2. avr 2025 | 11.64 | +2.37 |
Carter Bankshares | CARE | 2. avr 2025 | 16.14 | +0.56 |
Carters | CRI | 2. avr 2025 | 42.12 | +2.58 |
Cartesian Growth II A | RENE | 2. avr 2025 | 11.88 | 0.00 |
Cartesian Growth II Unit | RENEU | 2. avr 2025 | 11.69 | 0.00 |
Cartesian Therapeutics | RNAC | 2. avr 2025 | 12.95 | +3.68 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.